FDA CLASS II RECALL

     The Food and Drug Administration announced a Class II recall (https://www.accessdata.fda.gov/scripts/ires/?Product=210449)

                  for duloxetine manufactured by Towa Pharmaceutical Europe.  Lot # 220128, expiring December 2024.  

Class II recalls means exposure could trigger "temporary or medically reversible adverse health consequence.

Therefore it is extremely unlikely that will cause any problem for you. If you have this specific capsule from this manufacturer that expires 12/24, call your pharmacist for a replacement.